Medical & Marketing Manager

• Jul 2023 - Present

Medical Science Responsible NM&PH LATAM

• Mar 2020 - Aug 2022

Medical Science Responsible NM&PH LATAM•Developed for all Latin America interviews with focus groups of high scientific impact, getting to know the prescription habits of technologies• Contributed to the realization of 1 annual event for 4 years, where the most important opinion leaders in Latin America met to discuss topics of high scientific impact in therapies (Bariatrics, Gynecology, Neuromodulation, Pelvic Floor and Colorectal) that used our technologies. .• During my 6 years at Medtronic, I planned and developed a Training education model program which included 50 courses per year both e-learning and in presence, for Mexico and Latin America, with the highest technological and scientific quality, for the training of Medical Opinion Leaders, with the highest standards of compliance.• Conducted the review of promotional materials and speaker slides, so that they meet the compliance standards and regulatory aspects in each of the Latin American countries. Show less

COVID 19 Crisis Americas Member

• Mar 2020 - Aug 2022

COVID 19 Crisis Americas MemberStrongly participated in the COVID 19 crisis committee, providing medical-scientific support (training, telephone assistance, emotional support, etc.) during the pandemic for the employees of the production plants in Mexico, Dominican Republic, and Puerto Rico. Managing to strengthen the support and confidence in the staff, as well as the credibility in the actions taken by the crisis committee, so manufacturing plants could continue their processes with out having to stop at any time. Show less

Medical Affairs Manager NOLA (MITG)

• Aug 2019 - Aug 2021

•Formalized education linkage agreements with UNAM, one of the most important universities in Latin America, to carry out high-impact training, with university recognition in dry and wet (cadaveric) models.• Led the necessary steps within my area to obtain the ISO37001 (Anti-Bribery Management System), contributing to the Medtronic certification.

Medical Affairs Manager México (MITG)

• Aug 2016 - Aug 2019

Participated with the Value Base Health Care area in the possible modification of treatment guidelines in health policies. Managing to contribute to changes in Bariatric Surgery.

Head CR&D NOLA Vaccines

• Oct 2012 - Jul 2015

• Design and implement the strategy of clinical and regulatory research activities recovering and ensuring that the planning and execution of clinical studies in NOLA were in line with the strategic plans of the company and were carried out in accordance with the highest quality standards. •Structured the conduct of clinical studies in NOLA within the guidelines of good clinical practices, standard operating procedures, as well as interacting with KOL, and authorities from planning and execution, including safety aspects with a view of Medical Affairs. • Integrated and defined the structure of work team in the clinical research area, as well as the management of the members, for their training and way of working for NOLA, achieving a highly competitive team. • Managed a budget of approximately 2 million dollars to exercise it in the different NOLA countries, optimizing these resources, within the different clinical studies. • Resolved regulatory issues in Colombia, achieving Clinical Studies. Show less

Medical-Marketing Manager (Uro, GYN, Arthritis, SNC, Oncology)

• Jul 2008 - Dec 2012

• Achieved excellent relationships with the different Medical Societies (Urology, Mexican Federation of Gynecology and Obstetrics, Rheumatology, Neurology and Oncology, to facilitate continiued medical education. • Implemented the stratification for KOL payments according to their academic level, thus optimizing economic resources. • Directed Advisory Boards, to know the prescriptive habits of doctors, to design a medical strategy according to their needs. • Got the support of Opinion Leaders, to obtain letters with positive comments for the inclusion of drugs, in the national formulary according to medical-scientific bases. Show less

Clinical Research Manager

• Jul 2005 - May 2008

• Made strategic business decisions to increase from 3 to 36 clinical trials in the region (Mexico, Central America and Colombia) in the areas of Gynecology, renal transplantation, vaccines, oncology, arthritis and infectology in phases II, III and IIIB and some phase IV. • Develop the Opinion Leaders Program, to stratify them and have greater control of their evolution and growth, as well as the optimization of payments according to their level. • Made strategic business decisions to increase from 3 to 36 clinical trials in the region (Mexico, Central America and Colombia) in the areas of Gynecology, renal transplantation, vaccines, oncology, arthritis and infectology in phases II, III and IIIB and some phase IV. • Develop the Opinion Leaders Program, to stratify them and have greater control of their evolution and growth, as well as the optimization of payments according to their level.

Clinical Research & Medical Affairs Manager North LATAM

• Sep 1998 - Jul 2005

• Led the Project Management (Management, budget, resources, hiring of CRO) in Mexico of 6 international multicenter clinical studies, successfully concluding them and achieving the regulatory authorization of the molecules in question. • Contributed to the most profitable medical marketing tandem at that time with sales of more than 10 million dollars. • Contributed from the medical point of view in the launch of Prescription and Self-medication Molecules. • Contributed to various crisis committees for prescription molecules, for their defense in terms of safety profiles. • Coordinated various forums of opinion leaders, national and international, I even hosted Sir John Vane Nobel Prize in Medicine. • I was responsible for the Quality Assurance and Compliance area of ​​the Medical Department, to safeguard medical activities within an ethical framework. • Collaborated in the Duloxetine Joint Venture with Eli Lilly, developing the joint product launch strategy. • Led the Pharmacovigilance area, which did not exist, developing SOP's. Show less